Menu

Vir Biotechnology, Inc. VIR

Full chart Compare
Set alert

Price alert · VIR

All alert types
13.13 USD -0.02 (-0.15%)

At closeNov 11, 2026, 4:00 PM EST

13.00 -0.13 -0.99%

After hours · Nov 11, 4:00 PM ET

12.94 Day range 13.43
5.32 52-week range 14.38
YTD
+117.74%
1 year
+129.95%

Revenue & Expenses

Revenue by
Other Income → Expenses: $30.25MLicense And Collaboration Revenue → Revenue: $63.13MExpenses → Selling, General & Admin: $92.07MExpenses → Research & Development: $432.80MExpenses → Income Tax: $217.00KGross Profit → Expenses: $56.85MRevenue → Gross Profit: $56.85MRevenue → Cost of Revenue: $11.71MOther Revenue → Revenue: $3.39MNet Loss → Expenses: $437.99MGrant → Revenue: $2.04MOther Income$30.25MGross Profit$56.85MNet Loss$437.99MCost of Revenue$11.71MExpenses$525.09MSelling, General & Admin$92.07MResearch & Development$432.80MIncome Tax$217.00KRevenue$68.56MLicense And Collaboration Revenue$63.13MOther Revenue$3.39MGrant$2.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VIR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
68.56M74.20M86.18M1.62B1.10B
68.53M73.36M83.42M1.47B1.03B
-479.33M-587.16M-684.30M833.07M420.75M
-437.99M-521.96M-615.06M515.84M528.58M
-3.16-3.83-4.593.833.96
VIR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
234.11M312.33M254.84M861.31M356.41M
1.00B1.40B1.92B2.80B1.95B
237.55M248.43M328.82M724.13M522.42M
89.05M90.14M111.67M123.84M133.56M
765.28M1.15B1.59B2.08B1.43B
VIR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-391.78M-446.35M-778.78M1.66B-47.59M
310.37M499.37M164.63M-1.19B-140.81M
3.79M4.39M7.48M34.76M100.33M
-4.58M-3.93M-21.57M-68.01M-21.82M
-77.63M57.40M-606.68M504.55M-88.07M